262 related articles for article (PubMed ID: 38726287)
1. Controversial role of γδ T cells in colorectal cancer.
Yu X; Wang L; Niu Z; Zhu L
Am J Cancer Res; 2024; 14(4):1482-1500. PubMed ID: 38726287
[TBL] [Abstract][Full Text] [Related]
2. The γδ T cells dual function and crosstalk with intestinal flora in treating colorectal cancer is a promising area of study.
Lin P; Yan Y; Zhang Z; Dong Q; Yi J; Li Q; Zhang A; Kong X
Int Immunopharmacol; 2023 Oct; 123():110733. PubMed ID: 37579540
[TBL] [Abstract][Full Text] [Related]
3. Immune Effects of γδ T Cells in Colorectal Cancer: A Review.
Ma R; Yuan D; Guo Y; Yan R; Li K
Front Immunol; 2020; 11():1600. PubMed ID: 33013819
[TBL] [Abstract][Full Text] [Related]
4. Gamma-delta (γδ) T cells: friend or foe in cancer development?
Zhao Y; Niu C; Cui J
J Transl Med; 2018 Jan; 16(1):3. PubMed ID: 29316940
[TBL] [Abstract][Full Text] [Related]
5. T Cells in Colorectal Cancer: Unravelling the Function of Different T Cell Subsets in the Tumor Microenvironment.
Zheng Z; Wieder T; Mauerer B; Schäfer L; Kesselring R; Braumüller H
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511431
[TBL] [Abstract][Full Text] [Related]
6. Function of γδ T cells in tumor immunology and their application to cancer therapy.
Park JH; Lee HK
Exp Mol Med; 2021 Mar; 53(3):318-327. PubMed ID: 33707742
[TBL] [Abstract][Full Text] [Related]
7. PLA2G4A promotes right-sided colorectal cancer progression by inducing CD39+γδ Treg polarization.
Zhan Y; Zheng L; Liu J; Hu D; Wang J; Liu K; Guo J; Zhang T; Kong D
JCI Insight; 2021 Aug; 6(16):. PubMed ID: 34283812
[TBL] [Abstract][Full Text] [Related]
8. γδ T Cells in the Tumor Microenvironment-Interactions With Other Immune Cells.
Chan KF; Duarte JDG; Ostrouska S; Behren A
Front Immunol; 2022; 13():894315. PubMed ID: 35880177
[TBL] [Abstract][Full Text] [Related]
9. Multiomics profiling reveals the benefits of gamma-delta (γδ) T lymphocytes for improving the tumor microenvironment, immunotherapy efficacy and prognosis in cervical cancer.
Li J; Cao Y; Liu Y; Yu L; Zhang Z; Wang X; Bai H; Zhang Y; Liu S; Gao M; Lu C; Li C; Guan Y; Tao Z; Wu Z; Chen J; Yuan Z
J Immunother Cancer; 2024 Jan; 12(1):. PubMed ID: 38199610
[TBL] [Abstract][Full Text] [Related]
10. Colorectal Cancer-Infiltrating Regulatory T Cells: Functional Heterogeneity, Metabolic Adaptation, and Therapeutic Targeting.
Aristin Revilla S; Kranenburg O; Coffer PJ
Front Immunol; 2022; 13():903564. PubMed ID: 35874729
[TBL] [Abstract][Full Text] [Related]
11. Blocking senescence and tolerogenic function of dendritic cells induced by γδ Treg cells enhances tumor-specific immunity for cancer immunotherapy.
Si F; Liu X; Tao Y; Zhang Y; Ma F; Hsueh EC; Puram SV; Peng G
J Immunother Cancer; 2024 Apr; 12(4):. PubMed ID: 38580332
[TBL] [Abstract][Full Text] [Related]
12. Anti-metastatic potential of human Vδ1(+) γδ T cells in an orthotopic mouse xenograft model of colon carcinoma.
Devaud C; Rousseau B; Netzer S; Pitard V; Paroissin C; Khairallah C; Costet P; Moreau JF; Couillaud F; Dechanet-Merville J; Capone M
Cancer Immunol Immunother; 2013 Jul; 62(7):1199-210. PubMed ID: 23619975
[TBL] [Abstract][Full Text] [Related]
13. γδ T Cells and Tumor Microenvironment: From Immunosurveillance to Tumor Evasion.
Lo Presti E; Pizzolato G; Corsale AM; Caccamo N; Sireci G; Dieli F; Meraviglia S
Front Immunol; 2018; 9():1395. PubMed ID: 29963061
[TBL] [Abstract][Full Text] [Related]
14. Intrahepatic CD69
Bruni E; Cimino MM; Donadon M; Carriero R; Terzoli S; Piazza R; Ravens S; Prinz I; Cazzetta V; Marzano P; Kunderfranco P; Peano C; Soldani C; Franceschini B; Colombo FS; Garlanda C; Mantovani A; Torzilli G; Mikulak J; Mavilio D
J Immunother Cancer; 2022 Jul; 10(7):. PubMed ID: 35863820
[TBL] [Abstract][Full Text] [Related]
15. γδ T cells: Major advances in basic and clinical research in tumor immunotherapy.
Zhao Y; Dong P; He W; Zhang J; Chen H
Chin Med J (Engl); 2024 Jan; 137(1):21-33. PubMed ID: 37592858
[TBL] [Abstract][Full Text] [Related]
16. Strategies to Improve the Antitumor Effect of γδ T Cell Immunotherapy for Clinical Application.
Miyashita M; Shimizu T; Ashihara E; Ukimura O
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445615
[TBL] [Abstract][Full Text] [Related]
17. Adoptive T-Cell Therapy in Advanced Colorectal Cancer: A Systematic Review.
Juat DJ; Hachey SJ; Billimek J; Del Rosario MP; Nelson EL; Hughes CCW; Zell JA
Oncologist; 2022 Mar; 27(3):210-219. PubMed ID: 35274719
[TBL] [Abstract][Full Text] [Related]
18. Aberrantly Expressed Embryonic Protein NODAL Alters Breast Cancer Cell Susceptibility to γδ T Cell Cytotoxicity.
Siegers GM; Dutta I; Kang EY; Huang J; Köbel M; Postovit LM
Front Immunol; 2020; 11():1287. PubMed ID: 32636849
[TBL] [Abstract][Full Text] [Related]
19. The Therapeutic Potential of Tackling Tumor-Induced Dendritic Cell Dysfunction in Colorectal Cancer.
Subtil B; Cambi A; Tauriello DVF; de Vries IJM
Front Immunol; 2021; 12():724883. PubMed ID: 34691029
[TBL] [Abstract][Full Text] [Related]
20. The prognostic role of γδ T cells in colorectal cancer based on nomogram.
Ma R; Gong M; Sun T; Su L; Li K
Eur J Med Res; 2023 Oct; 28(1):467. PubMed ID: 37884961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]